chr11-62707136-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001122955.4(BSCL2):​c.60C>G​(p.Asp20Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00688 in 1,554,368 control chromosomes in the GnomAD database, including 622 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D20H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.037 ( 347 hom., cov: 33)
Exomes 𝑓: 0.0036 ( 275 hom. )

Consequence

BSCL2
NM_001122955.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.732

Publications

8 publications found
Variant links:
Genes affected
BSCL2 (HGNC:15832): (BSCL2 lipid droplet biogenesis associated, seipin) This gene encodes the multi-pass transmembrane protein protein seipin. This protein localizes to the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Naturally occurring read-through transcription occurs between this locus and the neighboring locus HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2).[provided by RefSeq, Mar 2011]
HNRNPUL2-BSCL2 (HGNC:49189): (HNRNPUL2-BSCL2 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2) and BSCL2 (Berardinelli-Seip congenital lipodystrophy 2 (seipin)) genes on chromosome 11. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Mar 2011]
GNG3 (HGNC:4405): (G protein subunit gamma 3) Guanine nucleotide binding proteins are heterotrimeric signal-transducing molecules consisting of alpha, beta, and gamma subunits. The gamma subunit determines the specificity of which signaling pathways will be affected by this particular complex. The protein encoded by this gene represents the gamma subunit of both inhibitory and stimulatory complexes. [provided by RefSeq, Jan 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002399981).
BP6
Variant 11-62707136-G-C is Benign according to our data. Variant chr11-62707136-G-C is described in ClinVar as Benign. ClinVar VariationId is 257498.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BSCL2NM_001122955.4 linkc.60C>G p.Asp20Glu missense_variant Exon 1 of 11 ENST00000360796.10 NP_001116427.1 Q96G97-4A0A024R540

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BSCL2ENST00000360796.10 linkc.60C>G p.Asp20Glu missense_variant Exon 1 of 11 1 NM_001122955.4 ENSP00000354032.5 Q96G97-4
HNRNPUL2-BSCL2ENST00000403734.2 linkn.*111C>G non_coding_transcript_exon_variant Exon 14 of 24 2 ENSP00000456010.1 H3BQZ7
HNRNPUL2-BSCL2ENST00000403734.2 linkn.*111C>G 3_prime_UTR_variant Exon 14 of 24 2 ENSP00000456010.1 H3BQZ7

Frequencies

GnomAD3 genomes
AF:
0.0369
AC:
5604
AN:
151928
Hom.:
347
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0171
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000647
Gnomad OTH
AF:
0.0206
GnomAD2 exomes
AF:
0.00831
AC:
1346
AN:
162046
AF XY:
0.00642
show subpopulations
Gnomad AFR exome
AF:
0.127
Gnomad AMR exome
AF:
0.00698
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000568
Gnomad OTH exome
AF:
0.00329
GnomAD4 exome
AF:
0.00362
AC:
5077
AN:
1402322
Hom.:
275
Cov.:
31
AF XY:
0.00320
AC XY:
2211
AN XY:
691666
show subpopulations
African (AFR)
AF:
0.129
AC:
4106
AN:
31946
American (AMR)
AF:
0.00728
AC:
260
AN:
35734
Ashkenazi Jewish (ASJ)
AF:
0.0000397
AC:
1
AN:
25184
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36530
South Asian (SAS)
AF:
0.000126
AC:
10
AN:
79464
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49664
Middle Eastern (MID)
AF:
0.00579
AC:
33
AN:
5704
European-Non Finnish (NFE)
AF:
0.000217
AC:
234
AN:
1079836
Other (OTH)
AF:
0.00743
AC:
433
AN:
58260
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
266
532
797
1063
1329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0369
AC:
5612
AN:
152046
Hom.:
347
Cov.:
33
AF XY:
0.0351
AC XY:
2612
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.127
AC:
5261
AN:
41406
American (AMR)
AF:
0.0171
AC:
261
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10586
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000647
AC:
44
AN:
68012
Other (OTH)
AF:
0.0204
AC:
43
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
238
476
714
952
1190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00340
Hom.:
6
Bravo
AF:
0.0405
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.130
AC:
180
ESP6500EA
AF:
0.000629
AC:
2
ExAC
AF:
0.00988
AC:
528
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 19, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Monogenic diabetes Benign:1
Jan 25, 2019
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG criteria: BA1 (14% in Africans, seen in previous cases, similar freq in Today/1000g), BS2 (22 homozygotes in ExAC)= benign (REVEL 0.224 and 7 predictors/BP4: conflicing evidence, not using) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
4.9
DANN
Benign
0.87
DEOGEN2
Benign
0.026
.;.;T;T;.;.;T;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.099
N
LIST_S2
Benign
0.50
T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0024
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.94
T
PhyloP100
-0.73
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.26
N;N;N;N;N;N;D;D
REVEL
Benign
0.22
Sift
Uncertain
0.024
D;D;T;D;D;D;.;.
Sift4G
Benign
0.15
T;T;T;.;T;T;.;.
Vest4
0.042
MutPred
0.12
Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);
MVP
0.45
ClinPred
0.0012
T
GERP RS
-4.2
PromoterAI
0.019
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.026
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115116507; hg19: chr11-62474608; API